CME Group (CME)
Financials · financial exchanges · NASDAQ
CME Group is the world's leading and most diverse derivatives marketplace, providing essential infrastructure for global risk management.
What CME Group does
CME Group operates global derivatives marketplaces, including the Chicago Mercantile Exchange, Chicago Board of Trade, New York Mercantile Exchange, and COMEX. The company provides venues for trading futures and options on futures across various asset classes, as well as clearing services and electronic trading platforms like Globex, BrokerTec, and EBS.
Themes: derivatives trading, financial market infrastructure, clearing and settlement, electronic trading platforms, market data analytics
Fundamentals
- Price$274.98 as of 2026-08-21 close
- Market cap$94.9B as of 2026-08-24
- 1-year return+0.6% 2025-08-21 close $273.32 → 2026-08-21 close $274.98
- P/E22.13 as of 2026-08-24
- Net margin+34.0% as of 2026-08-24
- Gross margin+96.0% as of 2026-08-24
- ROE+15.6% as of 2026-08-24
- Debt / equity0.13 as of 2026-08-24
- Revenue growth (YoY)+16.6% as of 2026-08-24
- Revenue CAGR (3y)+9.1% SEC XBRL
- Beta0.27 as of 2026-08-24
- Last reported earnings2026-07-22 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +2.0%; 1-year non-decreasing per-share dividend streak (SEC XBRL).
How CME compares in its sector
- price-to-earnings ratiotop 25% 525 covered Financials peers, as of 2026-08-24
- net profit margintop 25% 538 covered Financials peers, as of 2026-08-24
- operating margintop 10% 534 covered Financials peers, as of 2026-08-24
- gross margintop 10% 176 covered Financials peers, as of 2026-08-24
- return on equitymiddle range 575 covered Financials peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 347 covered Financials peers
- indicated dividend yieldmiddle range 453 covered Financials peers, as of 2026-08-24
- free cash flow (absolute dollars, latest fiscal year)top 10% 431 covered Financials peers, as of FY2025
Position among covered Financials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
CME is not currently in any published Top 10 list. Its scores are below.
Long-term score
56.6 #269 of 987 scored · #117 of 191 in Financials
Financial health 89th (free cash flow margin 33.4%, debt to equity 0.1) and profitability 77th (operating margin 83.8%, return on equity 15.6%); weakest is capital return (11th, consecutive years of dividend increases 1 year).
Short-term score
52.8 #614 of 1,704 scored · #102 of 277 in Financials
Setup 69th: day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 3% of the past ~6 months), which often precedes a bigger move; catalysts 69th: open-market insider buys in 90 days 25, analysts have raised their average price target by 0.1% since the prior reading; weakest is momentum 51st: near the top of its 14-day range (overbought). Its score is docked 10 points for overextended (RSI above 75 or stochastic above 90).
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, CME's dividend was covered by reported results (earnings payout 97%, free-cash-flow payout 94%). This describes past coverage, not a forecast.
- Earnings payout97% dividends / net income
- Free-cash-flow payout94% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How CME Group looks technically
CME Group (CME) is trading 1.3% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 43 trading days ago — a "death cross", a bearish long-term signal. A trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 24 (a reading of 25+ marks a strong trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 65, neither overbought (above 70) nor oversold (below 30). It just made a new 20-day high, its first since 2026-05-28, pushing above its recent trading range. It is 16.5% below its highest point of the past year. Day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 3% of the past ~6 months), which often precedes a bigger move.
Trend
7
| Distance from the 200-day | it is trading 1.3% below its 200-day average, the long-term trend line — a long-term downtrend | -1.3% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $251.87 | $251.87 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $278.57 | $278.57 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 18 calendar days ago — the swings before that are what the structure reading is measured on | 18 sessions |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 43 trading days ago — a "death cross", a bearish long-term signal | 43 sessions |
| Trend strength (14-day ADX) | a trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 24 (a reading of 25+ marks a strong trend) | 24.1 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 65, neither overbought (above 70) nor oversold (below 30) | 64.9 |
|---|---|---|
| Position in its 14-day range | it is trading right at the top of its 14-day range ($256.83 to $275.50) — its "stochastic" reading is 97 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 97.2 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 35 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $329.16 | $329.16 |
|---|---|---|
| From the 52-week high | it is 16.5% below its 52-week high (its highest price of the past year) | -16.5% |
| Above the 52-week low | it is 25.9% above its 52-week low (its lowest price of the past year) | +25.9% |
| Below the 52-week high | it is 16.5% below its highest point of the past year | 16.5% |
| Since a 20-day breakout | it just made a new 20-day high, its first since 2026-05-28, pushing above its recent trading range | 1 session |
| Since a 55-day breakout | it just made a new 55-day high, its first since 2026-05-28, pushing above its recent trading range | 1 session |
| All-time high | its highest closing price on record is $329.16 (set on 2026-03-03) | $329.16 |
| Given back of the 52-week move | over the past year its closes ranged ($218.58 to $326.46), and it has recovered around half of its fall from last year’s high — 52% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $285.25 to $288.70. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 52.3% |
| From the all-time high | it is 16.5% below its all-time high | -16.5% |
| Nearest price level | it is trading 0.8% above a support level at $272.90 — a price it turned at 10 times since 2025-04-04, most recently on 2026-08-03. Since 2024-08-21 it has 8 such levels below the current price and 3 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -0.8% |
| All-time low | its lowest closing price on record is $7.78 (set on 2002-12-06) | $7.78 |
| Above the all-time low | it is 3434.4% above its all-time low | +3,434% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 3% of the past ~6 months), which often precedes a bigger move | 3rd percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $6.43 between its high and its low — about 2.3% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $6.43 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $256.73 and $274.44 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $256.73 – $265.59 – $274.44 |
| Typical daily range (% of price) | its price moves about 2.3% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.3% |
| Stretch from the 200-day average | it is trading 0.6 daily ranges below its 200-day average price (1.3% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 0.6 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.82× |
|---|
Analyst
2
| Change in the average price target | analysts have raised their average price target by 0.1% since the prior reading | +0.1% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
2
| Since a doji | 3 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 3 sessions ago |
|---|---|---|
| Since a bullish engulfing | 1 session ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 1 session ago |
Price gaps
3
| Gap at the open | it opened on 2026-08-21 0.6% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and had not traded back through that level by the close | +0.6% |
|---|---|---|
| Open gap | it gapped 4.3% above the previous close 22 sessions ago and has not traded back through the level it left behind at 237.38 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +4.3% |
| Gap filled | a 3.6% gap down opened on 2026-06-17 has been "filled" 18 sessions ago — price traded back through the level the gap left behind, and it took 27 sessions to close | 18 sessions ago |
Price streaks
1
| Closing streak | it has closed higher 2 sessions in a row, a +3.01% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 2 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 13.5 percentage points (the stock gained 15.8% while the market gained 2.3%) | +13.5% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 8.0 percentage points (the stock lost 4.9% while the market gained 3.1%) | -8.0% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 21.8 percentage points (the stock lost 10.7% while the market gained 11.1%) | -21.8% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 19.9 percentage points (the stock gained 0.6% while the market gained 20.5%) | -19.9% |
Signal agreement
2
| Bullish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bullish state: a fresh 20-day high, MACD momentum is positive, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 3 of 9 |
|---|---|---|
| Bearish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, lagging the market over 6 months, near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 4 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 4.5% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 7.8% of the share price. | +4.5% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is sitting right on the average price paid so far this year, so the typical buyer over that stretch is roughly break-even. That average is $274.91 — a volume-weighted average of daily closes over 157 sessions, not a true tick-by-tick VWAP. | +0.0% |
|---|---|---|
| Vs the average paid since it last reported | the price is 4% above the average price paid since it last reported on 2026-07-22 (its 8-K), so the typical buyer over that stretch is showing a gain. That average is $263.31 — a volume-weighted average of daily closes over 23 sessions, not a true tick-by-tick VWAP. | +4.4% |
Price levels it has turned at before
CME last closed at $274.98 on 2026-08-21. Since 2024-08-21 it has turned at 8 prices below its last close and 3 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $272.90 | Support | 0.8% below the last close | turned there 10 times · 2025-04-04 to 2026-08-03 |
| $281.21 | Resistance | 2.3% above the last close | turned there four times · 2025-07-07 to 2026-05-11 |
| $265.14 | Support | 3.6% below the last close | turned there 7 times · 2025-03-19 to 2025-12-19 |
| $289.71 | Resistance | 5.4% above the last close | turned there six times · 2025-05-07 to 2026-05-04 |
| $259.14 | Support | 5.8% below the last close | turned there 7 times · 2025-03-25 to 2026-08-12 |
| $310.01 | Resistance | 12.7% above the last close | turned there three times · 2026-02-10 to 2026-05-19 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Broke out to a new 20-day high · in a Bollinger Band volatility squeeze · lagging the market · At the top of its 14-day range (stochastic above 80) · Trading at this year’s average price paid (anchored VWAP) | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low · bollinger bands
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (2.44 mean, 1=Strong Buy…5=Strong Sell) — 15 analysts
- Mean price target$284.13 range $230.00 – $330.00; median $286.00
Analyst estimates, as of 2026-08-19. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for CME
- Consensus EPS estimate$2.94 next reporting period, as of 2026-08-19
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Intense competition from domestic and foreign entities and market consolidation.","Cybersecurity threats and potential failure of critical electronic trading infrastructure.","Regulatory changes affecting products, market access, or operational requirements."]
What changed in the latest 10-Q
AI-assisted comparison of CME's 10-Q filed 2026-04-24 against the prior one filed 2025-10-24.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing references Annual Report on Form 10-K for year ended December 31, 2025, filed February 26, 2026 (vs. older filing referencing year ended December 31, 2024, filed February 27, 2025)
- Newer filing presents Q1 2026 vs. Q1 2025 comparison; older filing presents Q3 2025 vs. Q3 2024 and nine-month comparisons
- Newer filing total revenues $1,880.1M (Q1 2026) vs. $1,642.3M (Q1 2025), 14% increase
- Newer filing total expenses $570.4M vs. $534.3M, 7% increase
- Newer filing operating margin 69.7% vs. 67.5%
- Newer filing non-operating income $201.2M vs. $136.8M, 47% increase
- Newer filing net income $1,154.3M vs. $956.2M, 21% increase
- Newer filing diluted EPS $3.18 vs. $2.62, 21% increase
- Newer filing clearing and transaction fees $1,542.6M vs. $1,337.3M, 15% increase
- Newer filing market data and information services $224.1M vs. $194.5M, 15% increase
- Newer filing total contract volume 2,210.1M vs. 1,815.8M, 22% increase
- Newer filing average rate per contract $0.652 vs. $0.686, 5% decrease
- Newer filing includes detailed breakdown of net changes in clearing and transaction fees attributable to volume and rate changes
- Newer filing average daily volume by product line: Interest rates 18,674K vs. 15,029K (24% increase), Energy 3,985K vs. 2,903K (37% increase), Metals 1,682K vs. 732K (130% increase)
- Newer filing explains volume increases due to heightened geopolitical conflict in the Middle East
- Newer filing contract volume and average rate per contract disclosures explicitly exclude event contracts in addition to cash markets business and interest rate swaps
- Newer filing discusses Middle East geopolitical conflict impact on interest rate policy uncertainty, equity markets, energy/metals markets, and precious metals demand
- Newer filing shows E-mini Russell 2000 increase (33%) and Bitcoin futures increase (62%); discusses market shift from Nasdaq-100 to smaller cap Russell 2000
- Removed:
- Older filing presented nine-month ended September 30 comparative data; newer filing presents only quarterly data
- Older filing included electronic volume as percentage of total volume at 92-93%; newer filing shows 93% for both periods
- Older filing discussed tariff impacts on markets and Federal Reserve policy uncertainty in first half of 2025
- Older filing discussed weather conditions affecting agricultural and energy markets in 2025
- Older filing discussed lower Q3 2025 volume due to subsided market volatility and clarity on Federal Reserve policy
- Reworded:
- Newer filing states contract volume disclosures 'exclude trading volume for event contracts, the cash markets business as well as interest rate swaps' vs. older filing stating 'exclude trading volume for the cash markets business and interest rate swaps volume'
- Newer filing attributes volume increases to 'heightened geopolitical conflict in the Middle East' vs. older filing attributing changes to 'tariffs', 'geopolitical tensions', and 'weather conditions'
- Newer filing references 'uncertainty surrounding the United States Federal Reserve's (Federal Reserve) interest rate policy decision' due to Middle East conflict vs. older filing referencing uncertainty from 'anticipated and implemented tariffs'
- Newer filing describes cryptocurrency volume increase as result of 'broader cryptocurrency market repricing' vs. older filing approach
- Notes:
- The two filings cover different reporting periods (Q1 2026 vs. Q3 2025) and different comparison years, making some differences period-specific rather than policy or disclosure changes
- Older filing text appears truncated at foreign exchange products section, limiting completeness of comparison for that section
- Some differences reflect underlying business performance changes rather than MD&A disclosure or presentation changes
Risk Factors
- Added:
- In newer filing (2026-04-24): Added reference to 'the resilience of our electronic platforms and the soundness of our business continuity and disaster recovery plans, including in the event of cyberattacks and cyberterrorism or as impacted by a failure of or disruption at one of our suppliers' as a distinct bullet point
- In newer filing (2026-04-24): Page number changed from 33 to 31 for Item 1A. Risk Factors
- In newer filing (2026-04-24): Page number changed from 33 to 31 for Item 2
- In newer filing (2026-04-24): Page number changed from 34 to 32 for Item 6. Exhibits
- In newer filing (2026-04-24): Page number changed from 35 to 33 for SIGNATURES
- Removed:
- In older filing (2025-10-24): Trademark reference to 'OSTTRA is a trademark of MarkitSERV Limited' removed in newer filing
- In older filing (2025-10-24): Reference to 'new and existing geopolitical tensions or conflicts' removed in newer filing
- In older filing (2025-10-24): Reference to 'and the related uncertainty thereof' in tariffs and tax policy changes removed in newer filing
- In older filing (2025-10-24): Reference to joint venture with S&P Dow Jones and partnership with Google details removed in newer filing
- In older filing (2025-10-24): Reference to 'broker-dealers around the world' changed to 'broker-dealers' in newer filing
- Reworded:
- Older (2025-10-24): 'Unless otherwise noted, all amounts regarding contract volume' changed to 'all amounts regarding contract volume' (2026-04-24) - conditional language removed
- Older (2025-10-24): 'all amounts regarding contract volume and average rate per contract are for CME Group's listed futures and options on futures contracts unless otherwise noted' changed to 'all amounts regarding contract volume and average rate per contract are for CME Group's listed futures and options on futures contracts and exclude CME Group's event contracts' (2026-04-24)
- Older (2025-10-24): 'our ability to manage variable costs relating to CME Group's transition to the Google Cloud and minimize duplicative costs during the transition between maintaining the on-premise environment and the Google Cloud environment' changed to 'our ability to manage variable costs associated with CME Group's transition to the Google Cloud, and minimizing the duplicative costs of maintaining both on-premise and Google Cloud environments during the transition' (2026-04-24)
- Older (2025-10-24): 'exposure to risk through third parties' changed to 'exposure to risk from third parties' (2026-04-24)
- Older (2025-10-24): 'risks related to the performance, reliability and security of technology used by our third-party providers and third-party providers that our clients and third-parties rely on' changed to 'risks related to the performance, reliability and security of technology used by, or facilities provided by, our third-party providers and third-party providers that our clients and third-parties rely on' (2026-04-24)
- Older (2025-10-24): 'the ability to implement enhancements without failure or degradation of the performance of our trading and clearing systems and meeting our regulatory reporting obligations' changed to 'the ability to implement enhancements meeting our regulatory obligations and customer needs without failure or degradation of the performance of our trading and clearing systems' (2026-04-24)
- Notes:
- The newer filing text appears truncated at the end, cutting off mid-sentence with 'impact of CME Group pricing/', making complete comparison of closing sections uncertain
- The older filing text is also truncated at the end with text cut off at 'and our data cen', preventing full comparison of later risk factors
- Page numbering differences may reflect different document structure rather than content changes
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
2 open-market purchases and 0 open-market sales by insiders in the last 90 days.
- Last 90 days2 buys ($78186) · 0 sells — 1 buying insider
- Last 180 days2 buys ($78186) · 3 sells ($12M) — 1 buying, 2 selling insiders
Activity heuristic: net buying (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-06-25. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about CME's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Congressional trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 12 matched disclosures for CME from U.S. House Clerk Periodic Transaction Report filings.
Congressional trading disclosures →Institutional ownership (13F)
5 institutional 13F filers reported holding CME as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 52,216,206
- Reported value $15,422,056,431
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 1 increased, 4 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
CME had 6,213,476 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
Short interest as a percent of shares outstanding is not shown for CME because we do not hold a verified share count to divide it by. The reported figures above are unaffected.
- Reported short interest (shares) 6,213,476
- Prior settlement (shares) 5,837,310
- Reported change 6.44%
- Days to cover (reported) 2.26
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Intercontinental Exchange (ICE)
- CBOE Global Markets (CBOE)
- Nasdaq (NDAQ)
- London Stock Exchange Group
- Deutsche Börse (DB1)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare CME vs…
CME Group is found in…
CME ranks in…
CME shows up in…
Frequently asked questions
What does CME Group (CME) do?
CME Group operates global derivatives marketplaces, including the Chicago Mercantile Exchange, Chicago Board of Trade, New York Mercantile Exchange, and COMEX. The company provides venues for trading futures and options on futures across various asset classes, as well as clearing services and electronic trading platforms like Globex, BrokerTec, and EBS.
What sector is CME Group (CME) in?
CME Group (CME) is classified in the Financials sector. Its industry is financial exchanges. It trades on NASDAQ.
Does CME pay a dividend?
Yes — CME Group (CME) pays a dividend, with an indicated yield of about 2.03% and 1-year non-decreasing per-share dividend streak (SEC EDGAR XBRL) (market data, as of 2026-08-24). Informational only — not financial advice.
Who are CME Group's (CME) competitors?
Notable peers of CME Group (CME) include Intercontinental Exchange, CBOE Global Markets, Nasdaq, London Stock Exchange Group and Deutsche Börse. This peer set is informational only — not financial advice.
Has there been recent Congressional stock trading in CME?
Yes — we hold 12 matched STOCK Act disclosures for CME from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is CME Group (CME) overbought or oversold right now?
CME Group (CME) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 65, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on CME come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.